Proximagen Neuroscience News
Most Popular Proximagen Neuroscience Story
Proximagen strikes deal to buy Cambridge Biotechnology
Armed with an $82 million buyout fund, the UK's Proximagen says it has inked a deal to buy Cambridge Biotechnology from Sweden's Biovitrum. Proximagen--which raised 50 million pounds in a fundraising Read more...
Latest Headlines
- September 29, 2011
- October 22, 2009
- June 5, 2009
- October 15, 2008
- August 29, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
